184 related articles for article (PubMed ID: 21970832)
1. Gene therapy for primary immunodeficiency.
Booth C; Gaspar HB; Thrasher AJ
Curr Opin Pediatr; 2011 Dec; 23(6):659-66. PubMed ID: 21970832
[TBL] [Abstract][Full Text] [Related]
2. Gene therapy for PIDs: progress, pitfalls and prospects.
Mukherjee S; Thrasher AJ
Gene; 2013 Aug; 525(2):174-81. PubMed ID: 23566838
[TBL] [Abstract][Full Text] [Related]
3. Gene therapy for primary immunodeficiencies.
Kildebeck E; Checketts J; Porteus M
Curr Opin Pediatr; 2012 Dec; 24(6):731-8. PubMed ID: 23073463
[TBL] [Abstract][Full Text] [Related]
4. Gene therapy of inherited immunodeficiencies.
Santilli G; Thornhill SI; Kinnon C; Thrasher AJ
Expert Opin Biol Ther; 2008 Apr; 8(4):397-407. PubMed ID: 18352845
[TBL] [Abstract][Full Text] [Related]
5. Gene therapy for primary immunodeficiencies: current status and future prospects.
Qasim W; Gennery AR
Drugs; 2014 Jun; 74(9):963-9. PubMed ID: 24848753
[TBL] [Abstract][Full Text] [Related]
6. Gene Therapy Approaches to Immunodeficiency.
Ghosh S; Gaspar HB
Hematol Oncol Clin North Am; 2017 Oct; 31(5):823-834. PubMed ID: 28895850
[TBL] [Abstract][Full Text] [Related]
7. Progress and prospects: gene therapy for inherited immunodeficiencies.
Qasim W; Gaspar HB; Thrasher AJ
Gene Ther; 2009 Nov; 16(11):1285-91. PubMed ID: 19776764
[TBL] [Abstract][Full Text] [Related]
8. Lentiviral haemopoietic stem/progenitor cell gene therapy for treatment of Wiskott-Aldrich syndrome: interim results of a non-randomised, open-label, phase 1/2 clinical study.
Ferrua F; Cicalese MP; Galimberti S; Giannelli S; Dionisio F; Barzaghi F; Migliavacca M; Bernardo ME; Calbi V; Assanelli AA; Facchini M; Fossati C; Albertazzi E; Scaramuzza S; Brigida I; Scala S; Basso-Ricci L; Pajno R; Casiraghi M; Canarutto D; Salerio FA; Albert MH; Bartoli A; Wolf HM; Fiori R; Silvani P; Gattillo S; Villa A; Biasco L; Dott C; Culme-Seymour EJ; van Rossem K; Atkinson G; Valsecchi MG; Roncarolo MG; Ciceri F; Naldini L; Aiuti A
Lancet Haematol; 2019 May; 6(5):e239-e253. PubMed ID: 30981783
[TBL] [Abstract][Full Text] [Related]
9. Gene therapy for primary immunodeficiencies: Part 2.
Aiuti A; Bacchetta R; Seger R; Villa A; Cavazzana-Calvo M
Curr Opin Immunol; 2012 Oct; 24(5):585-91. PubMed ID: 22909900
[TBL] [Abstract][Full Text] [Related]
10. Lentiviral vectors for the treatment of primary immunodeficiencies.
Farinelli G; Capo V; Scaramuzza S; Aiuti A
J Inherit Metab Dis; 2014 Jul; 37(4):525-33. PubMed ID: 24619149
[TBL] [Abstract][Full Text] [Related]
11. Current progress on gene therapy for primary immunodeficiencies.
Zhang L; Thrasher AJ; Gaspar HB
Gene Ther; 2013 Oct; 20(10):963-9. PubMed ID: 23719067
[TBL] [Abstract][Full Text] [Related]
12. [Current status and future prospects of stem cell gene therapy for primary immunodeficiency].
Uchiyama T; Onodera M
Nihon Rinsho Meneki Gakkai Kaishi; 2013; 36(3):148-55. PubMed ID: 23812072
[TBL] [Abstract][Full Text] [Related]
13. Update on gene therapy for immunodeficiencies.
Kohn DB
Clin Immunol; 2010 May; 135(2):247-54. PubMed ID: 20071242
[TBL] [Abstract][Full Text] [Related]
14. Ten years of gene therapy for primary immune deficiencies.
Aiuti A; Roncarolo MG
Hematology Am Soc Hematol Educ Program; 2009; ():682-9. PubMed ID: 20008254
[TBL] [Abstract][Full Text] [Related]
15. Gene Therapy for the Treatment of Primary Immune Deficiencies.
Kuo CY; Kohn DB
Curr Allergy Asthma Rep; 2016 May; 16(5):39. PubMed ID: 27056559
[TBL] [Abstract][Full Text] [Related]
16. Perspectives of gene therapy for primary immunodeficiencies.
Chinen J; Puck JM
Curr Opin Allergy Clin Immunol; 2004 Dec; 4(6):523-7. PubMed ID: 15640693
[TBL] [Abstract][Full Text] [Related]
17. Update on the treatment of primary immunodeficiencies.
García JM; Español T; Gurbindo MD; Casas C C
Allergol Immunopathol (Madr); 2007; 35(5):184-92. PubMed ID: 17923072
[TBL] [Abstract][Full Text] [Related]
18. New frontiers in the therapy of primary immunodeficiency: From gene addition to gene editing.
Kohn DB; Kuo CY
J Allergy Clin Immunol; 2017 Mar; 139(3):726-732. PubMed ID: 28270364
[TBL] [Abstract][Full Text] [Related]
19. Haematopoietic stem cell transplantation for primary immunodeficiency syndromes: A 5-year single-centre experience.
Norman M; David C; Wainstein B; Ziegler JB; Cohn R; Mitchell R; O'Brien T; Russell S; Trahair T; Trickett A; Frith K; Gray P
J Paediatr Child Health; 2017 Oct; 53(10):988-994. PubMed ID: 28752571
[TBL] [Abstract][Full Text] [Related]
20. The Phenotype and Treatment of WIP Deficiency: Literature Synopsis and Review of a Patient With Pre-transplant Serial Donor Lymphocyte Infusions to Eliminate CMV.
Schwinger W; Urban C; Ulreich R; Sperl D; Karastaneva A; Strenger V; Lackner H; Boztug K; Albert MH; Benesch M; Seidel MG
Front Immunol; 2018; 9():2554. PubMed ID: 30450104
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]